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http:WHAT THIS PAPER ADDS
A variety of treatment options have been described for spontaneous isolated dissection of the superior
mesenteric artery (SIDSMA), including conservative treatment, endovascular stenting (ES) and surgical repair.
Although several treatment options are available, there are currently no consensus guidelines on the proper
management of symptomatic SIDSMA. Herein, we report a contemporary series of 17 patients presenting with
acute abdominal pain and describe the management strategy we adopted in cases of symptomatic SIDSMA and
found that conservative treatment without anticoagulation can be applied successfully to the patients with
symptomatic SIDSMA. ES is indicated if patients have compression of the true lumen or dissecting aneurysm
likely to rupture. ES can also be provided to the patients in whom initial conservative treatment failed, as
a rescue therapy.Objective: Spontaneous isolated dissection of the superior mesenteric artery (SIDSMA) is extremely rare. Various
treatment options are currently available, including conservative treatment, endovascular stenting (ES) and
surgical repair. Herein, we present our experience in the treatment of symptomatic SIDSMA.
Methods: A retrospective study was conducted on 17 consecutive patients with symptomatic SIDSMA from May
2002 to May 2012. Conservative treatment consisted of strict blood-pressure control, bowel rest, nasogastric
suction, intravenous ﬂuid therapy and nutritional support as required; fasting was released on resolution of
abdominal pain, and ﬂuid food was given ﬁrst; then, diet was resumed after complete resolution of abdominal
pain. The decision to intervene was based on patient symptoms and signs, as well as the morphological
characteristics of SMA dissection on computed tomography (CT) angiography. Self-expandable stents were placed
via the common femoral artery approach. ES was indicated in patients with severe compression of the true
lumen or dissecting aneurysm likely to rupture.
Results: All patients had acute-onset abdominal pain. Treatment included conservative treatment with the use of
anticoagulation in ﬁve and without in nine patients, respectively. Three patients with severe compression of the
true lumen or large dissecting aneurysm underwent ES as a primary treatment. ES was performed in two patients
in whom initial conservative treatment failed. Patients who underwent ES were maintained on anti-platelet
therapy for 3 months postoperatively. The median follow-up time was 24 months (range, 2e72 months). No
complications were associated with the SIDSMA or ES. The patency of stents was demonstrated on follow-up CT
scans up to 8.5 months (range, 4e38 months).
Conclusions: Conservative treatment without anticoagulation can be applied successfully to the patients with
symptomatic SIDSMA. Our strategy of restricting ES for these patients who have compression of the true lumen
or dissecting aneurysm likely to rupture (and for those with failed conservative treatment) was successful.
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//dx.doi.org/10.1016/j.ejvs.2013.01.039Spontaneous isolated dissection of superior mesenteric
artery (SIDSMA) is deﬁned as an SMA dissection without the
presence of the aortic dissection. Although this condition is
considered rare, the development of advanced imaging
technology, in particular, abdominal computed tomography
(CT) scan appears to have increased the detection of SMA
in recent years.1,2 A variety of treatment options have
also been described for SIDSMA, including conservative
Z.Z. Jia et al. 503treatment, endovascular stenting (ES) and surgical repair.3e7
Although several treatment options are available, there are
currently no consensus guidelines on the proper manage-
ment of symptomatic SIDSMA.7,8
Herein, we report a contemporary series of 17 patients
presenting with acute abdominal pain but no evidence of
peritonitis and describe the management strategy we
adopted in cases of symptomatic SIDSMA.
MATERIALS AND METHODS
Patients
A retrospective study was performed on 17 consecutive
patients (12 male, ﬁve female, all Han) with symptomatic
SIDSMA from May 2002 to May 2012 of the Second Hospital
of Changzhou Afﬁliated to Nanjing Medical University. All
patients were identiﬁed by CT angiography (CTA) in our
study. Signs of bowel-wall necrosis and perforation (e.g.,
abdominal wall rebound tenderness, muscle rigidity or
shock) were considered a contraindication for conservative
treatment and ES. Patients who underwent the procedure
provided written informed consent.
Diagnostic work-up and categorisation
Initial diagnosis of SIDSMA was made by a CT scan in all
patients. CT was performed by using an eight-multidetector-
row CT system (GE, Lightspeed, France) or a 64-
multidetector-row CT system (Philips, Rotterdam, The
Netherlands). CT technical parameters included: 512  512
matrix, 5-mm slice, 300 (GE) and 250 mA (Philips); 120 kV.
In addition, the features of CT ﬁndings9 include thrombosis
of the false lumen, intramural haematoma, dissecting
aneurysm and intimal ﬂap (Fig. 2).
Only the patients who needed to undergo ES did the
digital subtraction angiography (DSA). Femoral access was
gained by using a 5-French sheath and the SMA angiog-
raphy was performed in posterioreanterior and lateral
projection by using a 5-French catheter.
The initial CTA and DSA were assessed for entry and re-
entry points of the dissection, dissection length, patency
and degree of luminal stenosis at the dissected segment of
the SMA.
Sakamoto et al.10 have categorised SIDSMA into four
types based on contrast-enhanced CT scanning. Recently,
Yun et al.11 added total thrombotic occlusion of the SMAFigure 1. Angiographic catetrunk to Sakamoto’s classiﬁcation, and devised a new clas-
siﬁcation of three types based on angiographic ﬁndings
(Fig. 1) e type I: patent true and false lumina that show
entry and re-entry sites; type II: patent true lumen but no
re-entry ﬂow from the false lumen; type IIa: visible false
lumen but no visible re-entry site (blind pouch of false
lumen); type IIb: no visible false luminal ﬂow (thrombosed
false lumen), which usually causes true luminal narrowing;
and type III: SMA dissection with occlusion of SMA.
Treatment
The decision to manage conservatively, to place a stent or
to undergo surgery was based on patient symptoms and
signs, as well as the morphologic characteristics of SMA
dissection on CTA. The factors indicating ES included: ①
compression of the true lumen (degree of true lumen
compression larger than 50%) and aneurysmal dilation of
the SMA likely to rupture (Fig. 3, when the aneurysmal
diameter equal to or larger than the SMA diameter was
presumed, the false aneurysm was likely to rupture); ②
compression of the true lumen (degree of true lumen
compression larger than 75%); and ③ aneurysmal dilation
of the SMA likely to rupture. Aggravation of pain or
increasing size of aneurysmal dilation of the SMA at follow-
up CT was also considered indicative of ES in patients
undergoing conservative treatment (patient nos. 4 and 5).
Conservative treatment consisted of strict blood pressure
control, bowel rest, nasogastric suction, intravenous ﬂuid
therapy and nutritional support as required. During the
earlier part of this study, we used anticoagulation therapy in
ﬁve patients (patient nos. 6, 7, 8, 15 and 16), but all
subsequent patients received neither anticoagulation nor
anti platelet therapy. In patients with conservative treat-
ment, fasting was released on resolution of abdominal pain
and ﬂuid food was given ﬁrst; then, diet was resumed after
complete resolution of abdominal pain and conﬁrmation of
normal physical examination in all the patients. CT scan was
additionally checked at any time on aggravation of symp-
toms after the diagnosis.
ES was performed as a primary treatment in patients
with severe compression of the true lumen and large dis-
secting aneurysm (patient nos. 1e3) and for those with
failed conservative treatment (patient nos. 4 and 5). The
hydrophilic Terumo wire was used as the guide wire.
However, use of a hydrophilic wire in a friable dissectedgorisation of SIDSMA.
Figure 2. (Type IIb): A CT angiographic ﬁnding of SIDSMA, cross-
sectional view of compression of the true lumen by the throm-
bosed false lumen.
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or perforation. Self-expandable stents were sized to the
diameter of the normal proximal SMA and stents 10%
greater in diameter were chosen. To ensure proper coverage
of the entry site, it is important to position the proximal end
of the stent around 1 cm proximal to the proximal end of
the false lumen to avoid the inﬂuences of proximal short-
ening of the stent and inadvertent migration during
deployment. Clopidogrel 225 mg was given before the
procedure and heparinisation during the procedure. Anti-
platelet therapy was achieved in combination with aspirin
and clopidogrel post procedure. Clopidogrel 75 mg daily
was administered during 3 months post procedure and
continued with acetylsalicylic acid 100 mg daily.
Follow-up
Outpatient clinic visits were encouraged at 1, 6 months and
annually thereafter, at which time the clinical features
including the nature of abdominal pain (onset, duration,
severity and relation to meals) and the provoking eventFigure 3. (Patient no. 3, type IIa): The characteristic DSA ﬁndings
including partly compression of the true lumen or dissecting
aneurysm likely to rupture.(overeating, overdrinking and pancreatitis) were recorded
and assessed.Statistical analysis
The continuous variables were recorded as means  stan-
dard deviation (SD). The t-test was used to compare the
differences in two groups’ variables. All statistical analyses
were performed using statistical software SPSS (version
11.5). A value of P <0.05 was considered to indicate
a statistically signiﬁcant difference.
RESULTS
The clinical characteristics of the 17 patients are summar-
ised in Table 1. The median age is 57 (range 47e76) years.
Relevant co-morbidities included hypertension (52.9%),
diabetes mellitus (29.4%), hyperlipidaemia (17.6%),
smoking (23.5%) and atherosclerosis (29.4%). No patients
had identiﬁable risk factors such as Marfan’s syndrome,
trauma, ﬁbromuscular dysplasia or vasculitis. The time
interval between onset of symptoms and performance of
CTA was 7.5  3.9 h (range 2e32 h). All patients reported
abdominal pain (onset, duration, severity and relation to
meals) and this was identiﬁed by CT scans. No patient
exhibited signs of bowel wall infarction and perforation
(e.g., abdominal wall muscle rigidity or shock).
The median distance from the SMA ostium to the
beginning of SMA dissection is 23  12 mm (range, 9.6e
50 mm). The median length of SMA dissection was
49  26 mm (range, 22e120 mm). SISMAD lesions were
categorised into the following groups according to their
angiographic ﬁndings: 0% Type I, 29.4% Type IIa, 70.6% Type
IIb and 0% Type III.
Conservative treatment was initially tried in 14 patients.
Five patients (patient nos. 6, 7, 8, 15 and 16) underwent
anticoagulation therapy and all subsequent patients
received neither anticoagulation nor anti-platelet therapy.
Among them, 12 patients were successfully treated with
a median follow-up period of 30 months (range, 2e72
months), and serial CT scans demonstrated thrombosis and
obliteration of the false lumen with time. The median
fasting time was 8.5 days (range, 4e14 days), the abdom-
inal pain was resolved and the patients were discharged
without any signiﬁcant complications. No complications
associated with SMA dissection occurred during follow-up.
ES was performed in two patients in whom initial conser-
vative treatment failed. Patient no. 4 demonstrated a dis-
secting aneurysm at the 31-day follow-up CT scan after
conservative treatment. Patient no. 5 evidenced an
increasing diameter of SMA aneurysm from 2.6 to 5.8 mm
at the 9-day follow-up CT scan. These two patients were
treated successfully with ES.
Three patients (patient nos. 1e3) with severe compres-
sion of the true lumen or dissecting aneurysm likely to
rupture underwent emergency ES after diagnosis. Self-
expandable stents (ACCULINK carotid stent; nitinol, Abbot
Laboratories, Abbott Park, IL, USA) with diameters of up to
8 mm and overall lengths of up to 50 mm were used. The
Table 1. Clinical characteristics of SIDSMA in 17 patients.
No Age/sex Symptoms Risk factors Type Treatment Symptom change Follow-up
(months)
1 47/M Abdominal pain Hypertension, Smoking IIa ES Pain resolution 14
2 49/M Abdominal pain
radiating to
the back
Hypertension IIa ES Pain resolution 8
3 50/F Abdominal pain Hyperlipidaemia IIa ES Pain resolution 6
4 65/M Abdominal pain Hypertension, DM IIa CT-ES Pain resolution 20
5 53/F Abdominal pain e IIa CT-ES Pain resolution 38
6 55/M Abdominal pain,
Nausea/vomiting
Hypertension, Atherosclerosis. DM IIb CT Pain resolution 46
7 47/M Abdominal pain Hyperlipidaemia IIb CT Pain resolution 72
8 65/M Abdominal pain Hypertension, Smoking IIb CT Pain resolution 48
9 61/F Abdominal pain e IIb CT Pain resolution 2
10 55/M Abdominal pain Hypertension IIb CT Pain resolution 4
11 53/M Abdominal pain Smoking IIb CT Pain resolution 34
12 70/F Abdominal pain Hypertension, Atherosclerosis IIb CT Pain resolution 18
13 54/M Abdominal pain DM IIb CT Pain resolution 16
14 73/M Abdominal pain Smoking, Atherosclerosis IIb CT Pain resolution 12
15 63/F Abdominal pain Hypertension, DM IIb CT Pain resolution 38
16 57/M Abdominal pain Atherosclerosis IIb CT Pain resolution 43
17 76/M Abdominal pain Hypertension, Hyperlipidaemia, DM,
Atherosclerosis
IIb CT Pain resolution 10
*Age: years, conservative treatment: CT, diabetes mellitus: DM, CT-ES: started conservative treatment but converted to ES.
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was signiﬁcantly shorter than in the conservative treatment
group (P < 0.05). The dissecting aneurysm showed
complete obliteration after stent placement in patient no. 2,
and partial obliteration (i.e., the aneurysmal volume
reduced, shape of aneurysm changed and the false lumen
thrombosed) in patient nos. 1, 4 and 5, reduced (i.e., the
aneurysmal volume reduced, but the shape of aneurysm did
not change and there was no thrombus in the false lumen)
in patient no. 3 and excellent distal blood ﬂow was restored
and abdominal pain was completely resolved post-
operatively in all patients; the detailed information on the
technical aspects of stented patients is given in Table 2. The
median follow-up was 12 months (range, 6e38 months)
and repeated CT scans demonstrated thrombosis and
obliteration of the dissecting aneurysm with time and the
patency of the SMA without any in-stent restenosis (Fig. 4).
No ES-related complications were developed.
All patients attended follow-up, and the median follow-up
time was 24 months (range, 2e72 months). Repeated CT
scans demonstrated thrombosis and obliteration of the false
lumen and dissecting aneurysm with time and the patency of
the SMA without any in-stent restenosis. No patient received
surgical repair. The treatments and outcomes of each patient
are summarised in detail in Table 1.
DISCUSSION
SIDSMA is a very rare condition. The postmortem study
revealed an incidence of 0.06% in a series of 6666 autop-
sies.12 Recently, however, SIDSMA has been reported more
frequently.3,7,8,13 SIDSMA can be detected as an incidental
ﬁnding but may also cause drastic complications such
as bowel infarction and severe haemorrhage. Althoughapproaches such as conservative treatment, ES and surgical
repair have been previously reported, given the paucity of
SIDSMA, the optimal treatment for SIDSMA remains
a matter of some controversy.
Yun et al.11 reported that SIDSMA occurs mainly in male
patients in their ﬁfth decade. Furthermore, the underlying
causes of SIDSMA did not appear to be related to athero-
sclerotic risk factors such as hypertension. In our series,
SIDSMA occurs mainly in male patients (12 of 17 patients,
70.6%) in their ﬁfth decade (median age is 57 years) and
52.9% (9 of 17 patients) of them have hypertension.
The natural course of SIDSMA would be as follows:7,14 (1)
limited progression with thrombosis of the false lumen; (2)
progressive dissection to distal branches of the SMA; (3)
rupture through the adventitia; or (4) rapidly expanding
false lumen resulting in the narrowing or obliteration of the
true lumen. Thus, the primary objective of treatment in
SIDSMA is to limit the extension of dissection, to preserve
the blood ﬂow distally through the true lumen and to
prevent the rupture of the false lumen. Gobble et al.7
recently reviewed 106 SIDSMAs and reported that 12
(30.0%) among 43 patients with expectant therapy failed
and eight (34.8%) out of 23 patients with anticoagulation
failed. Moreover, anticoagulation required a prolonged
fasting period of up to 33 days (27.2 days on average).15
Progression of disease and aneurysmal dilatation in some
cases was reported16,17 despite the administration of
chronic anticoagulation therapy. Considering the afore-
mentioned treatment objectives of the SIDSMA and reports,
however, there has been no ﬁrm evidence to support
anticoagulation therapy in SIDSMA. In our series, 12
patients (70.6%) with symptomatic SIDSMA were treated
successfully by conservative treatment, ﬁve patients
Table 2. The detail technical aspects information of stented patients.
No Severe
compression of
the true lumen
Aneurysm Dissection with
side branch
involvement
Self-expandable stent
diameter/lengths
Fasting time (days) Aneurysm change
1 Yes Yes No 7 mm/30 mm 5 d Partly obliteration
2 Yes Yes Yes 7 mm/50 mm 4 d Complete obliteration
3 Yes Yes No 8 mm/30 mm 2 d Reduced
4 No Yes Yes 7 mm/40 mm 2 d Partly obliteration
5 Yes Yes Yes 7 mm/30 mm 4.5 d Partly obliteration
*Reduced means the aneurysmal volume reduced, but the shape of aneurysm didn’t change and no thrombus in the false lumen. Partly
obliterated means the aneurysmal volume reduced, shape of aneurysm be changed, and thrombosed false lumen.
506 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 5 May/2013underwent anticoagulation therapy and all subsequent
patients received neither anticoagulation nor anti-platelet
therapy. SMA ES is known to have a higher risk of stent
thrombosis than other site artery stents in the long term.3
To prevent acute or subacute thrombosis after ES, a stent
used for SMA needs to have minimal shortening, good
ﬂexibility and weaker radial force, and it must not change
location as a result of the continuous movement of the
mesentery;18 once did not want to submit the weakened
artery wall to excessive tension, the self-expandable stent is
usually recommended and used. ES to the entry tear site of
SMA dissection can cover the intimal ﬂap and occlude blood
inﬂow to the false lumen. The false lumen then is obliter-
ated by thrombosis. Radial force of the self-expandable
stent can easily overcome the pressure of the false
lumen, which is usually caused by fresh thrombus. Self-
expandable stents also provide sufﬁcient diameter of the
true lumen. A covered stent graft can be successfully used
to cover the dissecting broad-base pseudo-aneurysm of the
SMA, of which intimal ﬂap cannot be covered by an open
stent.19 It may more beneﬁcial to implant a covered stent
graft over the entry site of the dissection.20 As the covered
stent graft can cause the obliteration of multiple side
branches of the SMA, however, it is not usually recom-
mended. In the currently described patients, and indeed inFigure 4. (Patient no. 3, type IIa): A computed tomography
angiogram shows thrombosis and obliteration of the dissecting
aneurysm and patency of the stent without any in-stent restenosis
6 months postoperatively.most cases of segmental dissection with side-branch
involvement, which were treated successfully by open
stents, we used an open stent and achieved good results. In
our series, ES was offered as an initial treatment in three
patients whose aneurysmal dilation or true lumen was
severely compressed and secondary in two patients who
failed in conservative treatment. ES provided immediate
symptomatic improvement and prevented further progres-
sion of the false lumen with a shorter fasting time. With
a median follow-up of 12 months, the patency of the stents
was demonstrated by repeated CT scans. Therefore, our
strategy of restricting ES for those patients who have
compression of the true lumen or dissecting aneurysm likely
to rupture (and for those with failed conservative treat-
ment) was successful. Gobble et al.7 suggested that patients
presenting with acute abdominal pain should undergo
emergency ES to restore blood ﬂow to the small bowel. In
our series, all patients had acute-onset abdominal pain, and
most of them (70.6%) underwent conservative treatment
and got good result; therefore, conservative treatment is
a promising alternative in patients without compression of
the true lumen or dissecting aneurysm likely to rupture.
Gobble et al.7 suggested that open surgical repair should
not be delayed if symptoms persist for 24 h on anti-
coagulation also. In our series, symptoms persisted more
than 26 and 32 in two patients (patient nos. 1 and 2) until
diagnosed by CTA. From the CTA we could see the aneu-
rysmal dilation and severe compression of the true lumen.
The two patients underwent emergency ES, and got good
results; therefore, ES for these patients having compression
of the true lumen or dissecting aneurysm likely to rupture
(and for those with failed conservative treatment) was
successful even when the symptoms persisted for >24 h.
The current evidence of treatment of symptomatic SIDSMA
is summarised in Table 3.
It was reported that duplex-scan and CTA are useful tools
in surveillance of vascular interventions and abdominal
duplex-scan is effective for following haemodynamic
changes within the SMA, bowel movement and signs of
bowel ischaemia, such as wall thickening and intestinal
dilatation.6,21,22
Study limitations
The major limitation of this nonrandomised study is that its
retrospective nature does not allow for direct comparison
Table 3. Summary of current evidence of treatment of symptomatic SIDSMA (Including our results).
Cases A/C A/P CT ES CT-ES Surgery F/U (months) Out-come
Yun WS et al. (2008) 32 5 4 28 1 e 3 22 Uneventful
Cho YP et al. (2009) 7 7 1 7 e e e 23 Uneventful
Zerbib P et al. (2010) 7 7 7 5 e e 2 21 Uneventful
Min SI et al. (2011) 13 e e 7 4 2 e 27.5 Uneventful
Park YJ et al. (2011) 58 13 13 53 1 e 4 23 Uneventful
Cho BS et al. (2011) 30 5 e 23 5 1 1 38.8 Uneventful
Chu SY et al. (2011) 8 e 1 1 6 e e 16 Uneventful
(except 1 died
before Angiography)
Our study 17 5 e 12 3 2 e 19.4 Uneventful
*A/C: Anticoagulation in conservative treatment patients, A/P: anti platelet in conservative treatment patients, conservative treatment: CT,
CT-ES: started conservative treatment but converted to ES, F/U: follow-up.
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the study based on CT ﬁndings. Therefore, a number of
patients who presented with SMA occlusion, bowel infarc-
tion necessitating laparotomy, and died of bowel infarction
related to an SIDSMA who never had a CT scan or a lapa-
rotomy wound not have been included in our study. In
addition, the number of patients was few and the obser-
vation time was short.Recommendations
We propose the following algorithm for the treatment of
a symptomatic SIDSMA. If bowel perfusion is not compro-
mised and the SMA aneurysm is not likely to rupture in
patients with a symptomatic SIDSMA, they should initially
undergo conservative treatment without anticoagulation
and anti-platelet. ES is indicated if patients have compres-
sion of the true lumen of the SMA, or SMA aneurysm is
likely to rupture on initial CT scan. Patients initially treated
with conservative treatment should be monitored closely
and should undergo a follow-up CT scan 15 days, 1 month, 6
months and yearly after diagnosis, and CT scan was addi-
tionally checked at any time with aggravation of symptoms
after the diagnosis. Patients who underwent ES undergo
follow-up CT scan 1 month, 6 months and yearly after the
procedure. In cases involving aggravating symptoms, no
major relief of pain within 7 days or progression of SMA
dissection on follow-up CT scan, ES should be considered
without delay. Imaging surveillance in successfully treated
patients, by either conservative treatment or ES, should
include CT scans or duplex sonography at 1 month, 6
months and yearly thereafter. A symptomatic SIDSMA is
a rare entity; therefore, our recommendations should not
be taken as a consensus guideline.
CONCLUSIONS
In conclusion, conservative treatment is a promising alter-
native in selected patients with symptomatic SIDSMA, and
our strategy of restricting ES for these patients having
compression of the true lumen or dissecting aneurysm likely
to rupture (and for those with failed conservative treat-
ment) was successful.ACKNOWLEDGEMENT
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